Literature DB >> 8728357

Attitude of African-Americans regarding prostate cancer clinical trials.

S B Robinson1, M Ashley, M A Haynes.   

Abstract

The purpose of this study was to qualitatively assess attitudes associated with the willingness of African-Americans to participate in prostate cancer clinical trials. Fifty-six African-American males, 40 years of age and older, were recruited from South Central Los Angeles. Respondents were divided into lower or middle socio-economic groups based on education and occupation. Focus group discussions were conducted to assess their knowledge about prostate cancer and willingness to participate in prostate cancer clinical trials. In addition, information was obtained to identify their incentives and barriers towards participating in prostate cancer research. Middle socio-economic respondents expressed a greater willingness to participate in prostate cancer clinical trials than did men of lower socio-economic status. Many indicated that they would be more likely to participate if they were encouraged to do so by a physician or researcher who was viewed as being competent and compassionate. Barriers to participation in prostate cancer clinical trials included concerns about drug toxicity, medical experimentation and distrust of the medical establishment. Endeavors aimed at increasing minority representation in prostate cancer clinical studies should address these issues.

Entities:  

Mesh:

Year:  1996        PMID: 8728357     DOI: 10.1007/BF01682300

Source DB:  PubMed          Journal:  J Community Health        ISSN: 0094-5145


  18 in total

1.  Deferred treatment for prostate cancer.

Authors:  R Handley; T W Carr; D Travis; P H Powell; R R Hall
Journal:  Br J Urol       Date:  1988-09

2.  Participation of community hospitals in clinical trials: analysis of five years of experience in the Eastern Cooperative Oncology Group.

Authors:  C B Begg; P P Carbone; P J Elson; M Zelen
Journal:  N Engl J Med       Date:  1982-05-06       Impact factor: 91.245

3.  High 10-year survival rate in patients with early, untreated prostatic cancer.

Authors:  J E Johansson; H O Adami; S O Andersson; R Bergström; L Holmberg; U B Krusemo
Journal:  JAMA       Date:  1992 Apr 22-29       Impact factor: 56.272

4.  Radical perineal prostatectomy for clinical stage B2 carcinoma of the prostate.

Authors:  J S Elder; H J Jewett; P C Walsh
Journal:  J Urol       Date:  1982-04       Impact factor: 7.450

5.  Assuring access to state-of-the-art care for U.S. minority populations: the first 2 years of the Minority-Based Community Clinical Oncology Program.

Authors:  A Kaluzny; O Brawley; D Garson-Angert; J Shaw; P Godley; R Warnecke; L Ford
Journal:  J Natl Cancer Inst       Date:  1993-12-01       Impact factor: 13.506

6.  The role of focus groups in health education for cervical cancer among minority women.

Authors:  M Dignan; R Michielutte; P Sharp; J Bahnson; L Young; P Beal
Journal:  J Community Health       Date:  1990-12

7.  Black versus white racial differences in clinical stage at diagnosis and treatment of prostatic cancer in Connecticut.

Authors:  A P Polednak; J T Flannery
Journal:  Cancer       Date:  1992-10-15       Impact factor: 6.860

8.  Age, and size and grade of tumour predict prognosis in incidentally diagnosed carcinoma of the prostate.

Authors:  C M Goodman; A Busuttil; G D Chisholm
Journal:  Br J Urol       Date:  1988-12

9.  Natural history of localised prostatic cancer managed by conservative therapy alone.

Authors:  N J George
Journal:  Lancet       Date:  1988-03-05       Impact factor: 79.321

10.  Expectant management of localized prostatic cancer.

Authors:  W F Whitmore; J A Warner; I M Thompson
Journal:  Cancer       Date:  1991-02-15       Impact factor: 6.860

View more
  25 in total

1.  Recruiting African Americans into research on cognitive aging.

Authors:  G J McDougall; E C Holston; P Wilke
Journal:  Ethn Dis       Date:  2001       Impact factor: 1.847

2.  NMA's clinical trials program.

Authors:  G C Dennis
Journal:  J Natl Med Assoc       Date:  1998-12       Impact factor: 1.798

Review 3.  Recommendations of the clinical trials consensus panel. National Medical Association.

Authors: 
Journal:  J Natl Med Assoc       Date:  2000-10       Impact factor: 1.798

4.  African-American participation in clinical trials: situating trust and trustworthiness.

Authors:  L M Crawley
Journal:  J Natl Med Assoc       Date:  2001-12       Impact factor: 1.798

5.  Awareness of cancer information among Asian Americans.

Authors:  Grace X Ma; Linda Fleisher
Journal:  J Community Health       Date:  2003-04

6.  Recruitment and participation in clinical trials: socio-demographic, rural/urban, and health care access predictors.

Authors:  Claudia R Baquet; Patricia Commiskey; C Daniel Mullins; Shiraz I Mishra
Journal:  Cancer Detect Prev       Date:  2006-02-21

Review 7.  Recruiting vulnerable populations into research: a systematic review of recruitment interventions.

Authors:  Stacy J UyBico; Shani Pavel; Cary P Gross
Journal:  J Gen Intern Med       Date:  2007-03-21       Impact factor: 5.128

8.  Health disparities: a barrier to high-quality care.

Authors:  C Daniel Mullins; Lisa Blatt; Confidence M Gbarayor; Hui-Wen Keri Yang; Claudia Baquet
Journal:  Am J Health Syst Pharm       Date:  2005-09-15       Impact factor: 2.637

9.  Substantial family history of prostate cancer in black men recruited for prostate cancer screening: results from the Prostate Cancer Risk Assessment Program.

Authors:  Kathleen Mastalski; Elliot J Coups; Karen Ruth; Susan Raysor; Veda N Giri
Journal:  Cancer       Date:  2008-11-01       Impact factor: 6.860

Review 10.  A descriptive analysis of state legislation and policy addressing clinical trials participation.

Authors:  Claudia R Baquet; Shiraz I Mishra; Armin D Weinberg
Journal:  J Health Care Poor Underserved       Date:  2009-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.